Date: Tuesday 24 Apr 2012
Vectura, the pharma company specialising in treatments for respiratory diseases, says a trial of one of its development drugs has shown better results than the main competitor.
| Tuesday broker round-up | 24-Apr-2012 | ShareCast |
| Vectura study reaches end point of third phase o... | 02-Apr-2012 | ShareCast |
| New Homeserve director opens account | 10-Feb-2012 | ShareCast |
| Vectura trims R&D spend for fiscal 2011/12 | 11-Jan-2012 | ShareCast |
| Wednesday broker round-up - UPDATE | 11-Jan-2012 | ShareCast |
| Awards under share incentive plan | 25-May-2012 | 13:03 | RNS |
| Positive NVA237 Phase III data in COPD Patients | 17-May-2012 | 07:00 | RNS |
| Board appointment | 03-May-2012 | 07:00 | RNS |
| Total Voting Rights | 01-May-2012 | 07:00 | RNS |
| Final Results | 26-Apr-2012 | 07:00 | RNS |
| One to watch: Vectura | 13-Jul-2011 | The Scotsman |
| The potential for inhalable drugs to change medi... | 19-Feb-2007 | Times |
| Asthma venture gives Vectura boost | 22-Dec-2006 | The Independent |
| Samba Corus | 18-Nov-2006 | Sun |
| Vectura buys Innovata | 18-Nov-2006 | Guardian |
| Investment Column : Vectura | 24-May-2011 | The Independent |
| The Investment Column:Vectura Group | 25-Nov-2008 | The Independent |
| Margins no side-issue | 27-Nov-2007 | The Scotsman |
| Share tips: Keep taking the Vectura drug | 29-Jul-2007 | Sunday Telegraph |
| Inflation and Russia cast gloom over market | 18-Jul-2007 | The Independent |
No recent information was found.
| Newspaper and magazine share tips | 24-May-2011 | This Is Money |
| FTSE preview: Shares lower on Euro debt fear | 23-May-2011 | This Is Money |
| Newspaper and magazine share tips | 17-Nov-2010 | This Is Money |
| FTSE preview: Jitters ahead of inflation figures | 16-Nov-2010 | This Is Money |
| FTSE preview: Jitters ahead of inflation figures... | 16-Nov-2010 | This Is Money |
| Currency | UK Pounds |
| Share Price | 66.25p |
| Change Today | -0.50p |
| % Change | -0.75 % |
| 52 Week High | 104.00 |
| 52 Week Low | 51.00 |
| Volume | 107,026 |
| Shares Issued | 331.73m |
| Market Cap | £219.77m |
| Beta | 0.59 |
| RiskGrade | 246 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| No dividends found |
| Time | Volume / Share Price |
| 16:14 | 803 @ 65.25p |
| 16:02 | 3,084 @ 67.25p |
| 15:53 | 2,000 @ 66.23p |
| 15:32 | 177 @ 66.75p |
| 15:25 | 6,706 @ 65.37p |
You are here: research